Nucleic Acids Research, 1995, Vol. 23, No. 8 1284-1291
© 1995
RNA |
Bidirectional effectors of a group I intron ribozyme
Department of Molecular Genetics and Microbiology, UMDNJ-Robert Wood Johnson Medical School Piscataway, NJ 08854-5635, USA
* To whom correspondence should be addressed
Received February 23, 1995. Accepted March 9, 1995.
The group I self-splicing introns found in many organisms are competitively inhibited by L-arginine. We have found thatL-arginine acts stereoselectively on the Pc1.LSU nuclear group I intron of Pneumocystis carinil, competitively inhibiting the first (cleavage) step of the splicing reaction and stimulating the second (ligation) step. Stimulation of the second step is most clearly demonstrated in reactions whose first step is blocked after 15 min by addition of pentamidine. The guanidine moiety of arginine is required for both effects. L-Canavanine is a more potent inhibitor than L-arginine yet it falls to stimulate. L-Arginine derivatized on its carboxyl group as an amide, ester or peptide is more potent than L-arginine as a stimulator and inhibitor, with di-arginine amide and tri-arginine being the most potent effectors tested. The most potent peptides tested are 10 000 times as effective as L-arginine in inhibiting ribozyme activity, and nearly 400 times as effective as stimulators. Arginine and some of its derivatives apparently bind to site(s) on the ribozyme to alter its conformation to one more active in the second step of splicing while competing with guanosine substrate in the first step. This phenomenon indicates that ribozymes, like protein enzymes, can be inhibited or stimulated by non-substrate low molecular weight compounds, which suggests that such compounds may be developed as pharmacological agents actingon RNA targets.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
Y. Zhang and M. J. Leibowitz Folding of the group I intron ribozyme from the 26S rRNA gene of Candida albicans Nucleic Acids Res., June 15, 2001; 29(12): 2644 - 2653. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Miletti and M. J. Leibowitz Pentamidine Inhibition of Group I Intron Splicing in Candida albicans Correlates with Growth Inhibition Antimicrob. Agents Chemother., April 1, 2000; 44(4): 958 - 966. [Abstract] [Full Text] |
||||
![]() |
S. M. Testa, S. M. Gryaznov, and D. H. Turner In vitro suicide inhibition of self-splicing of a group I intron from Pneumocystis carinii by an N3' right-arrow P5' phosphoramidate hexanucleotide PNAS, March 16, 1999; 96(6): 2734 - 2739. [Abstract] [Full Text] [PDF] |
||||


